Assisted Reproductive Technology Act 2007

The Act casts a wide net. Registered ART providers (clinics, laboratories, solo practitioners) bear the heaviest compliance burden. Any person or corporation providing ART services for fee or reward or in the course of business must register (s 6(1)), maintain records for 50 years (s 31(2)), report births (s 33), and face penalties up to 1,600 penalty units for repeat prohibited-business offences (s 58).

Registered medical practitioners who undertake or supervise ART must ensure surrogacy assessment reports are considered (s 15A(2)) and may face disciplinary action rather than criminal penalty for breach. Counsellors must hold prescribed qualifications (s 12(2C)) and provide services at the point of care.

Gamete providers (donors and autologous users) are affected at every stage. They must be counselled, receive extended information before donating (s 13 Table item 4), give written consent on approved forms (s 17), and may modify or revoke that consent until implantation (s 17(4)). Donors are subject to the five-family limit (s 27), must supply detailed personal and medical history (s 30(1)), and can later access non-identifying information about offspring (s 39). Pre-2010 donors may have their historical records transferred without consent (s 41P) yet retain rights to update register entries (s 33B).

Women undergoing ART and their spouses receive mandatory counselling and information (s 12(1), s 13 Table items 1–2). They must be told about the central register, their own and their children’s rights to information, and the legal effect of donor consent (s 13(3)). In surrogacy cases they must obtain an independent assessment report (s 15A(1)). Recipients of donated gametes more than five years old are indirectly protected by the donor-life-check obligation (s 24).

Donor-conceived persons are the primary beneficiaries of the information regime. Adults may obtain identifying donor details (s 37(1)), non-identifying sibling data (s 37(2)), and, in limited cases, identifying sibling or donor information on welfare grounds (s 40A). Parents of minor donor-conceived children may access non-identifying donor and sibling information and, where life or serious health is at stake, identifying donor data (s 38). The Act explicitly contemplates descendants of offspring when defining “relevant medical history” (s 4).

Parties to surrogacy arrangements (birth parents, intended parents, gamete providers) fall under both the ART and surrogacy regimes. They may lodge information voluntarily (s 41C), update it post-parentage order (s 41C(2)), and exercise graduated disclosure rights (ss 41E–41G). Biological siblings of surrogacy-born persons have parallel rights (s 41F(3)).

The Secretary of the Ministry of Health is the central administrator, registrar, decision-maker on extensions and prohibitions, and disclosure gatekeeper. The Secretary may issue guidelines (s 26(2)), authorise destruction of pre-2010 records (s 41Q), direct health-service providers to supply information (s 34), and share data with the Registrar of Births, Deaths and Marriages (s 35) and interstate agencies (s 27(7)–(8)).

Inspectors and courts (Local Court, Supreme Court) enforce the regime. Finally, pre-2010 record holders (former providers, hospitals, laboratories) must retain material for 75 years or transfer it lawfully (Part 3A).

Duties of ART providers are granular. They must:

• Register and keep registration particulars current (ss 6–8).
• Ensure medical supervision (s 11), counselling availability (s 12), and informed consent (s 13).
• Obtain and record comprehensive identifying, medical and provenance data before any use (s 30, s 31).
• Comply with consent at every step—creation (s 18), treatment (s 19), research (s 20), supply (s 21), export (s 22), storage (s 25).
• Report births or absence thereof within statutory windows (s 33).
• Retain records 50 years (s 31(2)) and pre-2010 records 75 years (s 41O).
• Verify identity before acting on consent changes (s 17A) and confirm ongoing consent before major steps (s 17B).
• Refrain from treating children except for fertility preservation (s 29), creating incestuous embryos (s 28), or exceeding family limits (s 27).

Rights of gamete providers centre on control and later knowledge. They alone determine the uses to which their gametes or embryos may be put (s 17(2)), may revoke consent until the statutory cut-off (s 17(4)), and can access non-identifying offspring data (s 39) plus, with consent, identifying data about adult offspring (s 40B).

Rights of donor-conceived persons are information-focused. Adults have a statutory entitlement to donor ethnicity, physical characteristics, medical history, offspring sex and year of birth, and any voluntarily supplied personal statements (s 37(1)). They may also learn the sex and year of birth of donor siblings and, with sibling consent, identifying sibling details (s 37(2)). Welfare-based applications can unlock further identifying information (s 40A).

Rights of parents of minor donor-conceived children mirror the above but are limited to non-identifying data unless life or serious physical or psychological harm is at stake and no alternative source exists (s 38). A registered medical practitioner or psychologist must certify psychological risk (s 38(3)).

Rights of surrogacy-born adults, birth parents and gamete providers parallel the ART regime but are tailored to parentage orders and biological siblings (ss 41E–41G).

All parties have the right to counselling (s 12), to have voluntary information removed from the register if not otherwise required (s 33D(2)), and to be free from false or misleading representations (s 62).

Penalties are graduated and corporate multipliers apply. The most serious offences—unregistered operation (s 6(2)), incestuous embryo creation (s 28(1)), and repeat prohibited-business offences (s 58)—attract 1,000 penalty units for corporations or 400 penalty units plus two years’ imprisonment for individuals. Standard operational breaches (ss 11, 13, 18–22, 25(1), 27(1), 30, 17A, 17B) carry 800/400 penalty unit maxima. Record-keeping and reporting offences are 100–400 penalty units (ss 31, 33). Minor counselling failures attract only 50/25 penalty units (s 12(1)).

Part 5 inspectors possess broad powers: warrantless entry of registered premises at any time, reasonable-hours entry elsewhere, seizure, sampling, questioning, copying and detention of records (s 47). Obstruction or failure to answer attracts 100/50 penalty units (s 53). Search warrants under the Law Enforcement (Powers and Responsibilities) Act 2002 require Secretary notification (s 52(2)).

Part 6 prohibition orders allow the Secretary to bar individuals, directors and substantial shareholders from the industry for fixed or indefinite periods on breach of related legislation or loss of accreditation (s 57). These orders can extend to corporations in which prohibited persons hold >10% shares or management roles (s 57(4)). Breach of a prohibition order carries 800–1,600 penalty unit corporate maxima (s 58).

Evidentiary aids include certificates signed by the Secretary (s 66), onus on defendants to prove reasonable excuse (s 68), and corporate officer liability for knowing authorisation (s 65). Penalty notices and two-year limitation periods apply (ss 64, 63(3)). The Secretary may authorise destruction of pre-2010 records only if no person would be adversely affected (s 41Q).

The Act is expressly without prejudice to the Status of Children Act 1996 (parentage presumptions), the Mutual Recognition Act 1992 (Cth) and Trans-Tasman Mutual Recognition Act 1997 (Cth) (s 5). It dovetails with the Surrogacy Act 2010: s 15A mandates assessment reports before surrogacy-related treatment; Part 3 Division 3 places surrogacy data on the same central register; s 55A extends inspector powers to Surrogacy Act breaches by ART providers.

Federal legislation is referenced at multiple points. The Research Involving Human Embryos Act 2002 (Cth) and its NSW mirror (Research Involving Human Embryos (New South Wales) Act 2003) require RTAC accreditation for certain embryo use; the Act notes this in the Division 1 registration heading. The Prohibition of Human Cloning for Reproduction Act 2002 (Cth) and its NSW equivalent (Human Cloning for Reproduction and Other Prohibited Practices Act 2003) supply the 14-day embryo development limit (note to s 18) and appear as grounds for prohibition orders (s 57(3)(a)).

Health practitioner regulation is engaged via s 15A(3): breach of the surrogacy-assessment duty may constitute improper conduct under the Health Practitioner Regulation National Law (NSW). The Births, Deaths and Marriages Registration Act 1995 is used for donor-death checks (s 24(3)–(4)) and information sharing (s 35). The Human Tissue Act 1983 governs removal of gametes from deceased persons (note to s 23).

The Interpretation Act 1987 supplies singular/plural, de-facto-partner and general interpretation rules (notes to ss 4, 4B). Pre-2010 record obligations in Part 3A interact with privacy and confidentiality duties; s 69 expressly overrides confidentiality where disclosure is required or permitted.

The Act has been substantially rewritten since 2007. The Surrogacy Act 2010 inserted Division 3 of Part 3, s 15A, and related definitions, extending the central register to surrogacy-born persons and requiring independent counselling reports. This responded to the legalisation of altruistic surrogacy and the need for parallel information rights.

The Assisted Reproductive Technology Amendment Act 2016 (No 11) introduced Part 3A, the voluntary information provisions (ss 33A–33C), proactive Secretary powers (s 33D), updated family-limit rules (s 27), and mandatory birth-reporting windows. It also lengthened pre-2010 record retention to 75 years. The impetus was the realisation that many donor-conceived people born before 2010 could not access any information; the changes created a safety-net mechanism (ss 41T–41X) while preserving clinic records.

The Health Legislation Amendment Act (No 3) 2018 (No 73) was the most extensive rewrite. It substituted s 13, inserted ss 4A, 4B, 17A, 17B, 33E, 40A and 40B, amended consent, information-collection and register provisions, and clarified that “donated gamete” includes gametes later used to create donated embryos. These changes addressed practical problems: uncertain consent status of stored embryos, identity-verification failures, incomplete birth reporting, and inconsistent treatment of pre- and post-donation consent. The 2018 amendments also aligned the Act with contemporary privacy and welfare standards.

Minor 2024 amendments (No 22) adjusted the s 27 family-limit defence and information-sharing obligations. Each wave of reform has been driven by gaps exposed by technology, casework, and the legitimate expectations of donor-conceived adults for knowledge of their origins.

The legislation itself has generated limited reported litigation, but several controversies recur. First, the five-family limit (s 27) has been criticised as both too permissive (risk of inadvertent consanguinity) and too restrictive (denying donor-conceived siblings the chance to know each other). The due-diligence defence has never been judicially tested; its three mandatory steps (own records, donor inquiry, other-provider contact) set a high evidentiary bar.

Second, the interaction between s 23 (post-mortem use) and the Human Tissue Act 1983 has produced ethical debate but no reported NSW cases. The requirement for contemporaneous written consent from both donor and recipient has been described as overly rigid where families seek to honour a deceased partner’s wishes.

Third, pre-2010 record access (Part 3A) has been controversial. Clinics argued that 75-year retention is burdensome and that many records are incomplete or illegible. Donor-conceived applicants have complained that “accessible information” is narrowly defined (s 41S) and that the Secretary’s direction power (s 41V) is rarely used. No reported challenge has tested the validity of Secretary authorisations under s 41Q to destroy records.

Fourth, the Secretary’s proactive register powers (s 33D(1A)–(1C)) raise natural-justice questions. Although the Act requires notation of source (s 33D(1C)), there is no statutory duty to notify affected persons before entry. The 2018 amendments that inserted these powers have not yet been litigated.

Finally, the interface with Commonwealth prohibition-of-cloning legislation has produced academic controversy over whether “related treatment or procedure” in the s 4 ART-treatment definition could inadvertently capture mitochondrial-replacement therapy. No NSW prosecution has tested the boundary.

Most practitioners miss three subtle traps. First, the “donated gamete” definition in s 4B(1)(b) is retroactive: a gamete originally obtained for autologous use that is later used to create an embryo donated to a third party becomes a “donated gamete” for all purposes, triggering the 15-year storage clock from creation (s 25(3)(d)) and the family-limit rules. Clinics that simply rely on the original consent form can breach ss 26 and 27 without realising the status change.

Second, s 17B confirmation-of-consent obligations apply even to autologous embryos that were created years earlier. If the gamete provider has not been re-contacted within the regulatory window before a thaw-and-transfer cycle, the provider commits an 800-penalty-unit offence. The “reasonable steps” safe harbour is undefined; regulators expect documented attempts at least 14 days before the procedure.

Third, the interaction between s 31(1)(c1) and s 33(1A) creates a reporting black hole. If a clinic loses contact with a recipient after 15 months but before the 16-month reporting window closes, it must still report “I do not know” and supply all donor and embryo data. Failure to do so is a 400-penalty-unit corporate offence. Many clinics assume that if they never hear of a birth they have no obligation; the Act says the opposite.

Another trap is the s 27(4) information-sharing duty. A provider who receives a request from another provider must supply not only birth numbers but also the number of current pregnancies, embryos in storage, and known natural conceptions. Refusal is only 100 penalty units, but it exposes the recipient provider to the s 27(1) offence if it proceeds without the data. The due-diligence defence is unavailable if any of the three steps was omitted.

Finally, transitional clause 4A of Schedule 1 is often overlooked. Gametes donated before 1 January 2010 for “family completion” use are deemed to carry consent, bypass information-collection and reporting obligations, and are exempt from the five-family limit. However, the exemption applies only to the woman who previously conceived with that donor. Any other recipient re-triggers full compliance.

Compliance begins with registration hygiene. Maintain an up-to-date register extract, map every premises, named medical practitioner and counsellor, and file change-of-particulars notices by the next business day (s 8(2)). Automate annual-fee reminders; non-payment triggers automatic cancellation (s 7(10)).

Implement a consent-management system that captures the approved-form notice (s 17(1)), timestamps receipt, verifies identity per s 17A (or prescribed regulatory steps), and propagates modifications or revocations to every downstream provider within the shortest practicable time (s 17(5)–(6)). For embryos created from non-donated gametes, run the s 17B confirmation process no earlier than the regulatory window before each thaw, creation or transfer. Document every attempt.

Record-keeping must be forensic. For every gamete or embryo, store provenance, consent status, storage duration, and all uses (export, supply, research). For each recipient, record pregnancy outcome at 1–4 months and birth details at 10–15 months (s 30(5)–(8)). Retain everything 50 years (s 31(2)); for pre-2010 material, 75 years or transfer lawfully with dual notifications to the Secretary (s 41P). Use the approved form for all s 31 records.

Reporting discipline is binary: within two months of learning of a live birth, or between 15–16 months after treatment if birth status is unknown, upload the exact dataset required by s 33(1) or (1A). Voluntary lodgements (ss 33A–33C) should be encouraged and reviewed for accuracy before entry.

Family-limit compliance requires a three-step due-diligence protocol before every donor-cycle: internal database search, direct donor inquiry, and written request to every other known provider. Retain the replies. Use the Secretary’s register query facility (s 27(5)) whenever doubt exists.

Information-disclosure requests must be triaged by entitlement. Adult donor-conceived applicants receive the s 37 package automatically; parents of minors receive the narrower s 38 package. Welfare-based applications (s 38(1)(c), s 40A) require documented medical evidence and Secretary opinion. All voluntary-consent disclosures (s 40B) must be logged with proof of identity.

Surrogacy pathways demand an independent counsellor’s assessment report before any treatment (s 15A). The medical practitioner who supervises must personally satisfy himself or herself that provision is appropriate having regard to that report; failure is not criminal but may found a complaint to the Medical Council.

Training and audit should occur annually. All staff must understand the difference between basic and extended information lists (s 13(2)–(3)), the precise cut-off points for consent revocation (s 17(4)), and the pre-2010 versus post-2010 rules. Conduct mock inspector visits testing s 47 powers and ensure the certificate of authority is produced on demand (s 47(6)).

Finally, maintain a prohibition-order register. Any director, 10%+ shareholder or manager who has been convicted under related legislation or lost RTAC accreditation must be screened before appointment. If a prohibition order is served, cease all ART activities immediately and notify the Secretary of cessation (s 8(1)(a)).

A robust compliance program—centralised consent database, automated reporting calendar, annual legal refresher, and documented due-diligence checklists—will keep penalty exposure near zero while fulfilling the Act’s protective purposes.